MHRA launches Women's Health Programme to close evidence gaps on medicines and devices
The UK regulator says the programme will examine how the risks and benefits of medicines and medical devices may differ for women, working with patients, researchers, clinicians and industry.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a Women's Health Programme to improve the evidence base on medicines and medical devices for women. It will look in particular at how risks and benefits may differ between women and others, and at how better data and scientific advances can reflect women's needs. The agency announced the programme at the inaugural DIA-MHRA Global Summit in London, held on 16-17 November 2026 as part of London Life Sciences Week.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.